# Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

> **NCT06837844** · NA · RECRUITING · sponsor: **Kafrelsheikh University** · enrollment: 75 (estimated)

## Conditions studied

- Intrathecal Dexmedetomidine
- Adductor Canal Block
- Analgesia
- Total Knee Arthroplasty

## Interventions

- **DRUG:** Intrathecal Dexmedetomidine
- **DRUG:** Adductor Canal Block
- **DRUG:** Intrathecal Dexmedetomidine + Adductor Canal Block

## Key facts

- **NCT ID:** NCT06837844
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-20
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06837844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06837844, "Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06837844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
